129 related articles for article (PubMed ID: 7815372)
1. Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck.
McDonald JS; Jones H; Pavelic ZP; Pavelic LJ; Stambrook PJ; Gluckman JL
J Oral Pathol Med; 1994 Sep; 23(8):342-6. PubMed ID: 7815372
[TBL] [Abstract][Full Text] [Related]
2. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
3. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB-2 gene in human head and neck carcinoma.
Craven JM; Pavelic ZP; Stambrook PJ; Pavelic L; Gapany M; Kelley DJ; Gapany S; Gluckman JL
Anticancer Res; 1992; 12(6B):2273-6. PubMed ID: 1363518
[TBL] [Abstract][Full Text] [Related]
5. Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras.
Acin S; Li Z; Mejia O; Roop DR; El-Naggar AK; Caulin C
J Pathol; 2011 Dec; 225(4):479-89. PubMed ID: 21952947
[TBL] [Abstract][Full Text] [Related]
6. Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck.
Kiaris H; Spandidos DA; Jones AS; Vaughan ED; Field JK
Br J Cancer; 1995 Jul; 72(1):123-8. PubMed ID: 7599040
[TBL] [Abstract][Full Text] [Related]
7. Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy.
Ferris RL; Stefanika P; Xi L; Gooding W; Seethala RR; Godfrey TE
Laryngoscope; 2012 May; 122(5):1020-30. PubMed ID: 22447185
[TBL] [Abstract][Full Text] [Related]
8. Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumors.
Gapany M; Pavelic ZP; Gapany SR; Pavelic L; Li YG; Craven JM; Jones H; Biddinger P; Stambrook PJ; Gluckman JL
Cancer Detect Prev; 1993; 17(3):379-86. PubMed ID: 8402724
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.
Liu Y; Yu C; Qiu Y; Huang D; Zhou X; Zhang X; Tian Y
J Cancer Res Clin Oncol; 2012 Feb; 138(2):195-202. PubMed ID: 22086185
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes in head and neck cancer.
Irish JC; Bernstein A
Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
13. Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck.
Núñez F; Domínguez O; Coto E; Suárez-Nieto C; Pérez P; López-Larrea C
Surg Oncol; 1992 Dec; 1(6):405-11. PubMed ID: 1341278
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of oncogene expression in head and neck tumours.
Field JK; Lamothe A; Spandidos DA
Anticancer Res; 1986; 6(4):595-600. PubMed ID: 3019219
[TBL] [Abstract][Full Text] [Related]
16. Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.
Hsu CM; Lin PM; Lin HC; Lai CC; Yang CH; Lin SF; Yang MY
Anticancer Res; 2016 May; 36(5):2251-8. PubMed ID: 27127130
[TBL] [Abstract][Full Text] [Related]
17. [Expression of integrin αvβ3, CXC chemokine receptor 4 and CXC chemokine receptor 7 and their relationship with lymph node metastasis in squamous cell carcinoma of head and neck].
Li P; Li WL; Qi JX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Dec; 52(12):723-729. PubMed ID: 29275565
[No Abstract] [Full Text] [Related]
18. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the p53 gene in primary and metastatic head and neck carcinomas.
Sauter ER; Ridge JA; Trock B; Cleveland D; Whitley KV; Mohr RM; Klein-Szanto A
Laryngoscope; 1995 Jun; 105(6):653-6. PubMed ID: 7769953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
